Literature DB >> 20045465

Transient expression of an IL-23R extracellular domain Fc fusion protein in CHO vs. HEK cells results in improved plasma exposure.

Ka Fai Suen1, Mary S Turner, Feng Gao, Bo Liu, Alana Althage, Anthony Slavin, Weijia Ou, Elizabeth Zuo, Michael Eckart, Tomohisa Ogawa, Masao Yamada, Tove Tuntland, Jennifer L Harris, John W Trauger.   

Abstract

Transient transfection of mammalian cells in suspension culture has recently emerged as a very useful method for production of research-scale quantities of recombinant proteins. The most commonly used cell lines for this purpose are suspension-adapted HEK and CHO cells. We report here that the plasma exposure in mice of an IL-23R extracellular domain Fc fusion protein (IL23R-Fc) differed dramatically depending on whether the protein was prepared by transient transfection of HEK or CHO cells. Specifically, IL23R-Fc expressed using CHO cells had about 30-fold higher in vivo plasma exposure compared to the HEK-expressed protein. In contrast to their differing plasma exposures, the HEK- and CHO-expressed proteins had equivalent in vitro biological activity. Characterization of the CHO- and HEK-expressed IL23R-Fc proteins indicated that the differences in in vivo plasma exposure between them are due to differential glycosylation. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20045465     DOI: 10.1016/j.pep.2009.12.015

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  8 in total

1.  Rapid Antibody Glycoengineering in CHO Cells Via RNA Interference and CGE-LIF N-Glycomics.

Authors:  Pavlos Kotidis; Masue Marbiah; Roberto Donini; Itzcóatl A Gómez; Ioscani Jimenez Del Val; Stuart M Haslam; Karen M Polizzi; Cleo Kontoravdi
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Glycoengineering Chinese hamster ovary cells: a short history.

Authors:  Roberto Donini; Stuart M Haslam; Cleo Kontoravdi
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

3.  Protection against Th17 cells differentiation by an interleukin-23 receptor cytokine-binding homology region.

Authors:  Wei Guo; Cheng Luo; Chen Wang; Yue Zhu; Xin Wang; Xiangdong Gao; Wenbing Yao
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

4.  About making a CHO production cell line "research-friendly" by genetic engineering.

Authors:  Bernd Voedisch; Agnès Patoux; Jildou Sterkenburgh; Mirjam Buchs; Emily Barry; Cyril Allard; Sabine Geisse
Journal:  BMC Proc       Date:  2011-11-22

5.  Lentiviral expression system for the purification of secreted proteins from human cell cultures.

Authors:  Alexander Falkenhagen; Sabah Asad; Stanley E Read; Sadhna Joshi
Journal:  BMC Biotechnol       Date:  2016-09-02       Impact factor: 2.563

6.  A Peptide-Fc Opsonin with Pan-Amyloid Reactivity.

Authors:  James S Foster; Angela D Williams; Sallie Macy; Tina Richey; Alan Stuckey; Daniel Craig Wooliver; Richa Koul-Tiwari; Emily B Martin; Stephen J Kennel; Jonathan S Wall
Journal:  Front Immunol       Date:  2017-09-04       Impact factor: 7.561

7.  Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing.

Authors:  Yan Weng; Tetsuya Ishino; Annette Sievers; Saswata Talukdar; Jeffrey R Chabot; Amy Tam; Weili Duan; Kelvin Kerns; Eric Sousa; Tao He; Alison Logan; Darwin Lee; Dongmei Li; Yingjiang Zhou; Barbara Bernardo; Alison Joyce; Mania Kavosi; Denise M O'Hara; Tracey Clark; Jie Guo; Craig Giragossian; Mark Stahl; Roberto A Calle; Ron Kriz; Will Somers; Laura Lin
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

Review 8.  The regulatory mechanism and potential application of IL-23 in autoimmune diseases.

Authors:  De-Kai Xiong; Xiang Shi; Miao-Miao Han; Xing-Min Zhang; Na-Na Wu; Xiu-Yue Sheng; Ji-Nian Wang
Journal:  Front Pharmacol       Date:  2022-09-13       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.